Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Anthony Delacruz"'
Autor:
Ricardo B.V Fontes, Mena G. Kerolus, Ryan B. Kochanski, Rajeev K. Garg, Anthony DelaCruz, Vincent C. Traynelis
Publikováno v:
Neurospine, Vol 17, Iss 3, Pp 630-639 (2020)
Objective Airway obstruction after postoperative extubation is a dreaded but uncommon complication in patients undergoing circumferential cervical spine surgery (CCSS). The cuff leak test (CLT) has been utilized to assess air leak around the endotrac
Externí odkaz:
https://doaj.org/article/e56bd767ef83452cae344406a3cb8e63
Autor:
Joe M. O'Sullivan, Neal D. Shore, Anthony Delacruz, Bertrand Tombal, Aimee Vella Ripley, Ken Mastris, Brian Tomlinson, Lawrence Drudge-Coates, William Oh
Publikováno v:
Clinical Genitourinary Cancer, Vol. 16, no. 2, p. e411-e419 (2018)
Drudge-Coates, L, Oh, W K, Tombal, B, Delacruz, A, Tomlinson, B, Ripley, A V, Mastris, K, O'Sullivan, J M & Shore, N D 2017, ' Recognizing Symptom Burden in Advanced Prostate Cancer A Global Patient and Caregiver Survey ', Clinical genitourinary cancer, pp. 1-9 . https://doi.org/10.1016/j.clgc.2017.09.015
Drudge-Coates, L, Oh, W K, Tombal, B, Delacruz, A, Tomlinson, B, Ripley, A V, Mastris, K, O'Sullivan, J M & Shore, N D 2017, ' Recognizing Symptom Burden in Advanced Prostate Cancer A Global Patient and Caregiver Survey ', Clinical genitourinary cancer, pp. 1-9 . https://doi.org/10.1016/j.clgc.2017.09.015
BACKGROUND: Bone metastases in men with prostate cancer are often initially asymptomatic, resulting in delayed identification, diagnosis, and appropriate treatment. To assess how patients with advanced prostate cancer (aPC) communicate symptoms to he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e8f7525d15be9917108524a7a32852b
https://hdl.handle.net/2078.1/196689
https://hdl.handle.net/2078.1/196689
Autor:
Lawrence H. Schwartz, Tracy Curley, Dana E. Rathkopf, Chaitanya R. Divgi, Xiaoyu Jia, Christina Hong, Neeta Pandit-Taskar, Anthony Delacruz, Joseph A. O'Donoghue, Steven M. Larson, David B. Solit, William Kevin Kelly, Gretchen Gignac, Ryan D. Stephenson, Howard I. Scher, Glenn Heller, Susan F. Slovin, Michael J. Morris, Jorge A. Carrasquillo
Publikováno v:
Journal of Clinical Oncology. 27:2436-2442
Purpose Early studies of patients with castration-resistant metastatic prostate cancer (CRMPC) suggest that chemotherapy administered with a dose of a bone-seeking radiopharmaceutical is superior to chemotherapy alone. To build on this strategy and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca42c35a1f464a8048161e96d101b8c
https://doi.org/10.1200/jco.2008.20.4164
https://doi.org/10.1200/jco.2008.20.4164
Publikováno v:
Clinical journal of oncology nursing. 19(2)
Background Radium-223 dichloride, or radium-223, is a first-in-class alpha emitter that selectively targets bone metastases with high-energy, short-range alpha particles and is approved for the treatment of patients with castration-resistant prostate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c113d31dd404a9ffc7100792bd9c5a0a
https://pubmed.ncbi.nlm.nih.gov/25840395
https://pubmed.ncbi.nlm.nih.gov/25840395
Autor:
Neeta Pandit-Taskar, Susan F. Slovin, Michael J. Morris, Joseph A. O'Donoghue, Jennifer Halpern, Tracy Curley, Peter Smith-Jones, Angelo Nacca, Anthony Delacruz, Ronald D. Finn, Lawrence H. Schwartz, Nyasha Warren, Steven M. Larson, W. Kevin Kelly, Maria Batraki, Chaitanya R. Divgi, Philip O. Livingston, Howard I. Scher, David B. Solit
Publikováno v:
Clinical Cancer Research. 11:7454-7461
Background: Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein primarily expressed on benign and malignant prostatic epithelial cells. J591 is an IgG1 monoclonal antibody that targets the external domain of the PSMA. The relati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f3502626d86b61f19fc02ef1956bfe
https://doi.org/10.1158/1078-0432.ccr-05-0826
https://doi.org/10.1158/1078-0432.ccr-05-0826
Autor:
Tracy Curley, Louis Martone, W. Kevin Kelly, David Smith, Eric J. Small, Isan Chen, A. Dimitrios Colevas, Anthony Delacruz, William Oh, Matthew D. Galsky, Howard I. Scher
Publikováno v:
Journal of Clinical Oncology. 23:1439-1446
Purpose To evaluate the antitumor activity and safety of the epothilone B analog, ixabepilone, with or without estramustine phosphate (EMP), in chemotherapy-naive patients with progressive castrate metastatic prostate cancer. Patients and Methods Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec0e2458731d02104af58d46f4e5e94
https://doi.org/10.1200/jco.2005.09.042
https://doi.org/10.1200/jco.2005.09.042
Autor:
Anthony Delacruz, Dana E. Rathkopf, Daniel C. Danila, Howard I. Scher, Susan F. Slovin, Michael J. Morris, Gregory Shelkey, Mia DeNunzio, Brigit McLaughlin
Publikováno v:
Journal of Clinical Oncology. 35:204-204
204 Background: Studies in xenograft CRPC and PTEN-deficient prostate cancer models have shown synergistic anti-tumor activity of next-generation anti-androgens such as apalutamide when combined with PI3K/mTOR inhibitors such as everolimus. (Carver B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c1067cd12985c5a66b6f13ec6cc0318
https://doi.org/10.1200/jco.2017.35.6_suppl.204
https://doi.org/10.1200/jco.2017.35.6_suppl.204
Autor:
Karen A. Autio, Gregory Shelkey, Melanie Hullings, Mia DeNunzio, Dana E. Rathkopf, Anthony Delacruz, Howard I. Scher, Katherine Pisano, Susan F. Slovin, Michael J. Morris
Publikováno v:
Journal of Clinical Oncology. 34:e16529-e16529
e16529Background: MLN0128 is a first-in-class, dual mTOR inhibitor that has the potential to overcome resistance seen with standard rapalogs through inhibition of both TORC1 and TORC2. This phase I...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82589ea82538374c15ba347888bc2839
https://doi.org/10.1200/jco.2016.34.15_suppl.e16529
https://doi.org/10.1200/jco.2016.34.15_suppl.e16529
Autor:
Tracy Curley, Dana E. Rathkopf, Anthony Delacruz, Lawrence H. Schwartz, Susan F. Slovin, Michael J. Morris, Merrill J. Egorin, Neal Rosen, Macaulay Steers, Glenn Heller, Qing Ye, Steven M. Larson, Howard I. Scher, David B. Solit, S. Percy Ivy, Gopa Iyer
Publikováno v:
Cancer chemotherapy and pharmacology. 69(4)
To define maximum tolerated dose (MTD), clinical toxicities, and pharmacokinetics of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when administered in combination with docetaxel once every 21 days in patients with advanced solid tumor malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3b332dde185728b32e5088d2d040697
https://pubmed.ncbi.nlm.nih.gov/22124669
https://pubmed.ncbi.nlm.nih.gov/22124669
Autor:
Susan F. Slovin, Iain J. Webb, S. Moore-Cooper, Matthew D. Galsky, Mario A. Eisenberger, Yih Lee, Howard I. Scher, Anthony Delacruz, W. Kevin Kelly
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13)
Purpose MLN2704 is an immunoconjugate designed to deliver the maytansinoid antimicrotubule agent drug maytansinoid-1 directly to prostate-specific membrane antigen (PSMA)–expressing cells via the PSMA-targeted monoclonal antibody MLN591. This novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a51f07f128ed1b0138ecb1d2bcf3e3bb
https://pubmed.ncbi.nlm.nih.gov/18362364
https://pubmed.ncbi.nlm.nih.gov/18362364